Accellix was founded on the basis of creating a rapid, easy to use, automated cell phenotyping platform for use in the point of need environment, focuses on cell therapy with the principle of supporting its customers as they measure critical quality attributes at every QC phenotyping interrogation point when and where required.
Stringent process controls are needed to monitor critical parameters throughout the manufacturing process and the release of cell therapy products. These tests are generally performed on standard flow cytometers in centralized labs which require skilled technicians, high maintenance, a separate lab space, and time.
Accellix aims to bring the power of flow cytometry to the GMP manufacturing floor, automating the entire GMP cell phenotyping process from sample preparation to data analysis with the Accellix platform. Accellix brings automated sample preparation, flow cytometry and data analysis into the cell therapy GMP manufacturing suite.